Genetic lineage tracing defines myofibroblast origin and function in the injured heart

Nature Communications

Volumn 7, Issue , 2016, Pages

  Kanisicak, Onur ^a   Khalil, Hadi ^a   Ivey, Malina J ^b   Karch, Jason ^a   Maliken, Bryan D ^a   Correll, Robert N ^a   Brody, Matthew J ^a   Lin, Suh Chin J ^a   Aronow, Bruce J ^a   Tallquist, Michelle D ^b   Molkentin, Jeffery D ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALVASCULIN; CD31 ANTIGEN; CD45 ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CONNECTIVE TISSUE GROWTH FACTOR; CRE RECOMBINASE; FIBRILLIN; FIBRONECTIN; MESSENGER RNA; MICROFIBRILLAR ASSOCIATED PROTEIN 4; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; TAMOXIFEN CITRATE; TENASCIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 21; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; VIMENTIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; INTEGRASE; POSTN PROTEIN, MOUSE; TAMOXIFEN; TCF21 PROTEIN, MOUSE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CELLS AND CELL COMPONENTS; CLADISTICS; COLLAGEN; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ENGINEERING; INJURY; MUSCLE; RODENT;

ACUTE HEART INFARCTION; ADULT; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL FUNCTION; CELL LINEAGE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ECTOPIC EXPRESSION; EMBRYO; ENDOTHELIUM CELL; FEMALE; GENE LOCUS; GENE TARGETING; HEART FIBROBLAST; HEART MUSCLE INJURY; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SCAR FORMATION; SMOOTH MUSCLE CELL; ANIMAL; CARDIAC MUSCLE; GENETICS; HEART INFARCTION; METABOLISM; PATHOLOGY; TRANSGENIC MOUSE;

MUS;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BIOMARKERS; CELL ADHESION MOLECULES; FEMALE; INTEGRASES; MALE; MICE; MICE, TRANSGENIC; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOFIBROBLASTS; TAMOXIFEN;

EID: 84979220596     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms12260     Document Type: Article

References (57)

1. Shah, A. M., Mann, D. L. In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. Lancet 378, 704-712 (2011).
2. Ertl, G., Frantz, S. Healing after myocardial infarction. Cardiovasc. Res. 66, 22-32 (2005).
3. Borthwick, L. A., Wynn, T. A., Fisher, A. J. Cytokine mediated tissue fibrosis. Biochim. Biophys. Acta 1832, 1049-1060 (2013).
4. Davis, J., Molkentin, J. D. Myofibroblasts: trust your heart and let fate decide. J. Mol. Cell. Cardiol. 70, 9-18 (2014).
5. Kis, K., Liu, X., Hagood, J. S. Myofibroblast differentiation and survival in fibrotic disease. Expert Rev. Mol. Med. 13, e27 (2011).
6. Asli, N., Xaymardan, M., Harvey, R. Epicardial origin of resident mesenchymal stem cells in the adult mammalian heart. J. Dev. Biol. 2, 117 (2014).
7. Acharya, A. et al. The bHLH transcription factor Tcf21 is required for lineagespecific EMT of cardiac fibroblast progenitors. Development 139, 2139-2149 (2012).
8. Wessels, A. et al. Epicardially derived fibroblasts preferentially contribute to the parietal leaflets of the atrioventricular valves in the murine heart. Dev. Biol. 366, 111-124 (2012).
9. Cai, C. L. et al. A myocardial lineage derives from Tbx18 epicardial cells. Nature 454, 104-108 (2008).
10. Braitsch, C. M., Kanisicak, O., van Berlo, J. H., Molkentin, J. D., Yutzey, K. E. Differential expression of embryonic epicardial progenitor markers and localization of cardiac fibrosis in adult ischemic injury and hypertensive heart disease. J. Mol. Cell. Cardiol. 65, 108-119 (2013).
11. Moore-Morris, T. et al. Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. J. Clin. Invest. 124, 2921-2934 (2014).
12. Zeisberg, E. M. et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med 13, 952-961 (2007).
13. Widyantoro, B. et al. Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition. Circulation 121, 2407-2418 (2010).
14. Kramann, R. et al. Perivascular Gli1\+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell 16, 51-66 (2015).
15. van Amerongen, M. J. et al. Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction. J. Pathol. 214, 377-386 (2008).
16. Crawford, J. R., Haudek, S. B., Cieslik, K. A., Trial, J., Entman, M. L. Origin of developmental precursors dictates the pathophysiologic role of cardiac fibroblasts. J. Cardiovasc. Transl. Res. 5, 749-759 (2012).
17. Haudek, S. B. et al. Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc. Natl Acad. Sci. USA 103, 18284-18289 (2006).
18. Koumas, L., Smith, T. J., Feldon, S., Blumberg, N., Phipps, R. P. Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. Am. J. Pathol. 163, 1291-1300 (2003).
19. Strutz, F. et al. Identification and characterization of a fibroblast marker: FSP1. J. Cell Biol. 130, 393-405 (1995).
20. Kong, P., Christia, P., Saxena, A., Su, Y., Frangogiannis, N. G. Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis. Am. J. Physiol. Heart Circ. Physiol. 305, H1363-H1372 (2013).
21. Hudon-David, F., Bouzeghrane, F., Couture, P., Thibault, G. Thy-1 expression by cardiac fibroblasts: lack of association with myofibroblast contractile markers. J. Mol. Cell. Cardiol. 42, 991-1000 (2007).
22. Smith, C. L., Baek, S. T., Sung, C. Y., Tallquist, M. D. Epicardial-derived cell epithelial-to-mesenchymal transition and fate specification require PDGF receptor signaling. Circ. Res. 108, e15-e26 (2011).
23. Pinto, A. R. et al. Revisiting cardiac cellular composition. Circ. Res. 118, 400-409 (2016).
24. Yata, Y. et al. DNase I-hypersensitive sites enhance alpha1(I) collagen gene expression in hepatic stellate cells. Hepatology. 37, 267-276 (2003).
25. Goodpaster, T. et al. An immunohistochemical method for identifying fibroblasts in formalin-fixed, paraffin-embedded tissue. J. Histochem. Cytochem. 56, 347-358 (2008).
26. Wang, J., Zohar, R., McCulloch, C. A. Multiple roles of a-smooth muscle actin in mechanotransduction. Exp. Cell Res. 312, 205-214 (2006).
27. Snider, P. et al. Origin of cardiac fibroblasts and the role of periostin. Circ. Res. 105, 934-947 (2009).
28. Oka, T. et al. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ. Res. 101, 313-321 (2007).
29. Shimazaki, M. et al. Periostin is essential for cardiac healing after acute myocardial infarction. J. Exp. Med. 205, 295-303 (2008).
30. Yamamoto, M. et al. A multifunctional reporter mouse line for Cre-and FLP-dependent lineage analysis. Genesis. 47, 107-114 (2009).
31. Ali, S. R. et al. Developmental heterogeneity of cardiac fibroblasts does not predict pathological proliferation and activation. Circ. Res. 115, 625-635 (2014).
32. Furtado, M. B. et al. Cardiogenic genes expressed in cardiac fibroblasts contribute to heart development and repair. Circ. Res. 114, 1422-1434 (2014).
33. Snider, P. et al. Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart. Circ. Res. 102, 752-760 (2008).
34. Bax, N. A. et al. Matrix production and remodeling capacity of cardiomyocyte progenitor cells during in vitro differentiation. J. Mol. Cell. Cardiol. 53, 497-508 (2012).
35. Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R., Forster, I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8, 265-277 (1999).
36. Alva, J. A. et al. VE-Cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells. Dev. Dyn. 235, 759-767 (2006).
37. Wirth, A. et al. G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat. Med. 14, 64-68 (2008).
38. Lorts, A., Schwanekamp, J. A., Baudino, T. A., McNally, E. M., Molkentin, J. D. Deletion of periostin reduces muscular dystrophy and fibrosis in mice by modulating the transforming growth factor-beta pathway. Proc. Natl Acad. Sci. USA 109, 10978-10983 (2012).
39. Song, K. et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 485, 599-604 (2012).
40. Hinz, B. et al. The myofibroblast: one function, multiple origins. Am. J. Pathol. 170, 1807-1816 (2007).
41. Nurnberg, S. T. et al. Coronary artery disease associated transcription factor TCF21 regulates smooth muscle precursor cells that contribute to the fibrous cap. PLoS Genet. 11, e1005155 (2015).
42. Gustafsson, E., Brakebusch, C., Hietanen, K., Fassler, R. Tie-1-directed expression of Cre recombinase in endothelial cells of embryoid bodies and transgenic mice. J. Cell Sci. 114, 671-676 (2001).
43. Tang, Y., Harrington, A., Yang, X., Friesel, R. E., Liaw, L. The contribution of the Tie2\+ lineage to primitive and definitive hematopoietic cells. Genesis 48, 563-567 (2010).
44. van Berlo, J. H. et al. c-kit\+ cells minimally contribute cardiomyocytes to the heart. Nature 509, 337-341 (2014).
45. Verrou, C., Zhang, Y., Zurn, C., Schamel, W., Reth, M. Comparison of the tamoxifen regulated chimeric Cre recombinases MerCreMer and CreMer. Biol. Chem. 380, 1435-1438 (1999).
46. Quaggin, S. E. et al. The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. Development 126, 5771-5783 (1999).
47. Acharya, A., Baek, S. T., Banfi, S., Eskiocak, B., Tallquist, M. D. Efficient inducible Cre-mediated recombination in Tcf21 cell lineages in the heart and kidney. Genesis. 49, 870-877 (2011).
48. Patten, R. D., Hall-Porter, M. R. Small animal models of heart failure: development of novel therapies, past and present. Circ. Heart Fail. 2, 138-144 (2009).
49. Kaiser, R. A. et al. Targeted inhibition of p38 mitogen-activated protein kinase antagonizes cardiac injury and cell death following ischemia-reperfusion in vivo. J. Biol. Chem. 279, 15524-15530 (2004).
50. Wilkins, B. J. et al. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ. Res. 94, 110-118 (2004).
51. Chen, Y. et al. Left ventricular failure produces profound lung remodeling and pulmonary hypertension in mice: heart failure causes severe lung disease. Hypertension 59, 1170-1178 (2012).
52. Lin Shiau, S. Y., Huang, M. C., Lee, C. Y. Mechanism of action of cobra cardiotoxin in the skeletal muscle. J. Pharmacol. Exp. Ther. 196, 758-770 (1976).
53. Krampert, M., Heldin, C. H., Heuchel, R. L. A gain-of-function mutation in the PDGFR-b alters the kinetics of injury response in liver and skin. Lab. Invest. 88, 1204-1214 (2008).
54. Sayed, N. et al. Transdifferentiation of human fibroblasts to endothelial cells: role of innate immunity. Circulation 131, 300-309 (2015).
55. Guo, M., Wang, H., Potter, S. S., Whitsett, J. A., Xu, Y. SINCERA: a pipeline for single-cell RNA-Seq profiling analysis. PLoS Comput. Biol. 11, e1004575 (2015).
56. Karch, J. et al. Bax and Bak function as the outer membrane component of the mitochondrial permeability pore in regulating necrotic cell death in mice. Elife 2, e00772 (2013).
57. Brody, M. J. et al. Ablation of the cardiac-specific gene leucine-rich repeat containing 10 (Lrrc10) results in dilated cardiomyopathy. PLoS ONE 7, e51621 (2012).